All News about Lexaria Bioscience Corp WTVia ACCESSWIRE
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study
December 20, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria’s Human Oral Nicotine Study Begins Dosing
December 20, 2022
Via ACCESSWIRE
Lexaria's Human Clinical Hypertension Study a Success
October 27, 2022
Via ACCESSWIRE
Lexaria Discusses Valuation Metrics for Biotech Industry
August 11, 2022
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Lexaria Welcomes Dr. Catherine Turkel to its Board of Directors
September 02, 2022
Via ACCESSWIRE
Lexaria Receives New Patent in Mexico
August 31, 2022
Via ACCESSWIRE
Via AccessWire
Topics
Intellectual Property
Via AccessWire
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|